OpenAI researcher Miles Wang in talks to launch AI drug discovery startup at $2B valuation

Lightspeed is in discussions to lead the funding round for the venture, which would focus on AI-driven drug discovery. Wang is a researcher at OpenAI known for contributions to language models.

Featured · Miles Wang